Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Clinical trial results Sarcoidosis-associated small fiber neuropathy: In a blinded, placebo-controlled trial, 28 days of daily subcutaneous ARA-290 administration in patients with documented small nerve fiber loss produced significant improvements
ALT levels significantly decreased following treatment with glutathione for 4 months
In the U.S., you can report side effects to the FDA at www.safetyreporting.hhs.gov or by calling 888-SAFEFOOD (888-723-3366)
Injectable GHK-Cu sold through unregistered websites, peptide-sales sites, or research-chemical vendors is not the subject of this action and is not legal under 503A regardless
Related: Repair & Recovery Peptides | Compare with TB-500 | Research Peptides Guide Batch-specific third-party documentation available
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
